公开(公告)号：US11484514B2

公开(公告)日：2022-11-01

申请号：US16957432

申请日：2018-12-20

Applicant: NUBEBE CO., LTD. ,  HUMAN HERB CO., LTD.

Inventor： Young Woo Lim ,  Ji Myeong Ok ,  Woon Ho Lee ,  Young Bin Kim

IPC: A61P3/04 ,  A61K36/346 ,  A61K36/488 ,  A61K36/882 ,  A61K36/49 ,  A61K36/8994 ,  A61K36/31 ,  A61K36/736 ,  A61K36/8945 ,  A61K36/185 ,  A61K47/02 ,  A61K47/46 ,  A61K36/534 ,  A61K36/744 ,  A61K36/538 ,  A61K36/708 ,  A61K33/04 ,  A61K36/64 ,  A61K36/65 ,  A61K31/137 ,  A61K9/19 ,  A61K36/258 ,  A61K36/481 ,  A61K36/284 ,  A61K36/54 ,  A61K36/9068 ,  A61K36/076 ,  A61K36/752 ,  A61K36/725 ,  A61K36/734 ,  A61K36/575 ,  A61K36/884 ,  A61J3/06 ,  A61K9/28 ,  A61K36/17 ,  A61K36/62

Abstract: An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which is prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated ephedra powder agent so that an ephedrine content is 3.0-4.0%; determining a weight of the concentrated ephedra powder agent according to each constitution of Sasang constitutional medicine, and manufacturing a side effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the concentrated ephedra powder agent; mixing the concentrated ephedra powder agent and the side effect-preventing powder agent with a variance of a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects; and tableting the mixture of the prepared ephedra powder agent and side effect-preventing powder agent.